drugset / Trial / NCT00116896
Phase I Study of Cisplatin Plus OSI-7904L in Patients With Solid Tumors
Open-labelTreatment
Summary
This is a Phase I, open-label, dose escalation, study of the combination of cisplatin and OSI-7904L given on Day 1 every 21 days in patient who have advanced solid tumors.
Timeline
- Start
- 2003-06
- Primary completion
- —
- Completion
- 2004-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cisplatin | Other / unclassified | — | — |
| Subject | OSI-7904 | Small molecule | — | — |